Extremities

Conventus Orthopaedics announces milestone of 700+ Cage implantations

MINNEAPOLIS, Dec. 19, 2016 /PRNewswire/ — Conventus Orthopaedics, Inc. announced that over 700 patients now have been treated with the industry’s first expandable fracture cage, an innovative solution to fracture repairs in the upper extremity using a 3-dimensional approach. The Conventus Cage™, made of nitinol, a memory shape alloy, expands within the bone creating robust fixation and preventing further collapse of the fracture by providing a rigid internal scaffold upon completion of the procedure.

Conventus currently has five FDA-cleared indications in the upper extremity and the company is pursuing additional indications in the lower extremity and other areas of the skeletal anatomy.  Clinical follow-up of the first cage implantations is over four years now, showing not only excellent fracture repair but also fewer complications and reduced pain with faster recoveries for the patients.

“For years, surgeons have expressed the need for more versatile and reliable surgical options to repair simple to complex fractures,” said Paul Buckman, Conventus Orthopaedics CEO. “The Conventus Cages expand what is possible in patient care by enabling surgeons to repair a wider variety of fractures through less invasive means.”  Eric Fulkerson, M.D. of Muir Orthopaedics, Walnut Creek, CA said, “The Conventus Cage offers a solution that delivers reliably stable fracture repairs with consistently decreased recovery times and decreased pain for my patients. The innovative Cage design allows an expansion of fracture patterns treated with fixation as opposed to primary arthroplasty.” Since the Cage is implanted into bone, instead of onto bone, the potential for interference of hardware, as well as the need for a future surgery to remove fixation, is significantly reduced.  Andrew Schmidt, M.D., Chief of Orthopaedics, Hennepin County Medical Center, added, “For especially problematic fractures, such as those in the proximal humerus, the results after Cage fixation seem to be better, with more rapid return of motion and a dramatically lower incidence of surgical complications.”  Paul Paterson, M.D., orthopaedic surgeon in Buffalo, NY added, “The Conventus Cage offers tremendous stability of the fracture—better than plates and screws—through the use of 3-dimensional fixation. These fractures just do not move post repair.”

Conventus’ 3-dimensional Cage platform technology, emphasizes preservation of tissues and blood supply at the fracture site, creating a strong foundation by stabilizing bone fragments and facilitating early motion through less invasive procedures.

Conventus continues to expand their product portfolio and surgical applications in their quest to provide solutions throughout the entire musculoskeletal system.

For more information regarding use of the device please refer to www.conventusortho.com.

 

About Conventus Orthopaedics, Inc.
Conventus Orthopaedics, Inc. was founded by a team of medical device professionals and physicians with the sole purpose of improving patient care by creating a platform technology with less invasive solutions to a broad range of challenging periarticular fractures. Taking its name from the Latin word for coming together or union, Conventus Orthopaedics is focused on creating less invasive solutions for fractures in and around the joints. The company is dedicated to working with surgeons to improve healing and enable their patients’ return to normal activities.

 

SOURCE Conventus Orthopaedics, Inc.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button